These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10099812)

  • 21. Hepatitis C: the 'silent stalker'.
    Harkness GA
    Am J Nurs; 2003 Sep; 103(9):24-5. PubMed ID: 14506802
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy of combined interferon and ribavirin for treatment of hepatitis C.
    Brown JL
    Lancet; 1998 Jan; 351(9096):78-9. PubMed ID: 9439486
    [No Abstract]   [Full Text] [Related]  

  • 23. r-Interferon alfa-2b/ribavirin combined therapy followed by low-dose r-interferon alfa-2b in chronic hepatitis C interferon nonresponders.
    Perasso A; Testino G; Ansaldi F; Venturino V; Icardi GC
    Hepatology; 1999 Jan; 29(1):297-8. PubMed ID: 9935339
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatitis C. Understanding the issues.
    Miller SK
    Adv Nurse Pract; 2000 Dec; 8(12):49-50, 87-8. PubMed ID: 12397910
    [No Abstract]   [Full Text] [Related]  

  • 25. Chronic HCV infection: public health threat and emerging consensus. Vienna, Austria, October 27-28, 1995.
    Dig Dis Sci; 1996 Dec; 41(12 Suppl):1S-135S. PubMed ID: 9011465
    [No Abstract]   [Full Text] [Related]  

  • 26. [Current knowledge in the treatment of chronic hepatitis C].
    Pirotte J
    Rev Med Liege; 1995 Dec; 50(12):501-4. PubMed ID: 8570988
    [No Abstract]   [Full Text] [Related]  

  • 27. The epidemiology and control of hepatitis C infection.
    Gungabissoon U
    Nurs Times; 2003 Aug 5-11; 99(31):24-5. PubMed ID: 13677115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined antiviral therapy for recurrent hepatitis C virus after liver transplantation.
    Fontana M; Ciuffreda D; Moradpour D; Pascual M
    Transplantation; 2007 Feb; 83(4):525-6. PubMed ID: 17318091
    [No Abstract]   [Full Text] [Related]  

  • 29. Marketing scam spoils hep C treatment.
    Proj Inf Perspect; 1998 Dec; (26):6. PubMed ID: 11366498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mortality rate during interferon alfa-ribavirin combination therapy of chronic hepatitis C.
    Soza A; Hoofnagle JH
    Hepatology; 2003 Jul; 38(1):267. PubMed ID: 12830010
    [No Abstract]   [Full Text] [Related]  

  • 31. Hepatitis C: new treatment overview.
    Stoia J
    AIDS Treat News; 1998 Sep; (302):5-6. PubMed ID: 11365763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hepatitis C: revisited treatment].
    Siciliano RF; Boulos M
    Arq Gastroenterol; 2004; 41(1):1-2. PubMed ID: 15499416
    [No Abstract]   [Full Text] [Related]  

  • 33. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.
    McHutchison JG; Gordon SC; Schiff ER; Shiffman ML; Lee WM; Rustgi VK; Goodman ZD; Ling MH; Cort S; Albrecht JK
    N Engl J Med; 1998 Nov; 339(21):1485-92. PubMed ID: 9819446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Interferon-alpha and ribavirin: advances in the therapy of chronic hepatitis C].
    Zeuzem S
    Dtsch Med Wochenschr; 1999 May; 124(20):636-42. PubMed ID: 10370387
    [No Abstract]   [Full Text] [Related]  

  • 35. [Peginterferon alpha combined with ribavirin for the treatment of chronic hepatitis C].
    Xu Y; Wang JB
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jun; 19(6):415-6. PubMed ID: 22053369
    [No Abstract]   [Full Text] [Related]  

  • 36. Recovery from chronic hepatitis C in long-term responders to ribavirin plus interferon alfa.
    Fontaine H; Chaix ML; Lagneau JL; Bréchot C; Pol S
    Lancet; 2000 Jul; 356(9223):41. PubMed ID: 10892765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C - what does the future hold?
    Bain VG
    Can J Gastroenterol; 2000; 14(7):571-2. PubMed ID: 10978941
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of HCV-related mantle-cell lymphoma with ribavirin and pegylated interferon Alfa.
    Levine AM; Shimodaira S; Lai MM
    N Engl J Med; 2003 Nov; 349(21):2078-9. PubMed ID: 14627800
    [No Abstract]   [Full Text] [Related]  

  • 39. Combination treatment of interferon alpha-2b and ribavirin in comparison to interferon monotherapy in treatment of chronic hepatitis C genotype 4 patients.
    el-Zayadi A; Selim O; Haddad S; Simmonds P; Hamdy H; Badran HM; Shawky S
    Ital J Gastroenterol Hepatol; 1999; 31(6):472-5. PubMed ID: 10575565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ribavirin approved for hepatitis C combination treatment.
    James JS
    AIDS Treat News; 1998 Jun; (No 297):7. PubMed ID: 11365595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.